Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma

被引：7
|
作者：
Rodgers, Thomas D. [1 ]
Baran, Andrea [1 ]
Reagan, Patrick M. [1 ]
Casulo, Carla [1 ]
Zent, Clive [1 ]
Evans, Andrew [2 ]
Burack, Richard [2 ]
Williams, AnnaLynn M. [1 ]
Friedberg, Jonathan W. [1 ]
Barr, Paul M. [1 ]
机构：
[1] Univ Rochester, Wilmot Canc Inst, Rochester, NY 14627 USA
[2] Univ Rochester, Dept Pathol, Rochester, NY 14627 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 188卷 / 04期
关键词：
NON-HODGKIN-LYMPHOMA; SINGLE-AGENT LENALIDOMIDE; RITUXIMAB;
D O I：
10.1111/bjh.16302
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E33 / +
页数：4
相关论文
共 50 条
  • [41] Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
    Mondello, Patrizia
    Steiner, Normann
    Willenbacher, Wolfgang
    Ferrero, Simone
    Ghione, Paola
    Marabese, Alessandra
    Pitini, Vincenzo
    Cuzzocrea, Salvatore
    Mian, Michael
    ONCOLOGIST, 2016, 21 (09): : 1107 - 1112
  • [42] Osteolytic lesions in patients with relapse of diffuse large B-cell lymphoma treated with lenalidomide
    Schuelper, Nikolai
    Flohr, Antonius
    Truemper, Lorenz
    Wulf, Gerald G.
    ANNALS OF HEMATOLOGY, 2014, 93 (11) : 1929 - 1930
  • [43] Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: A case report
    Krawczyk K.
    Jurczak W.
    Gałązka K.
    Gruchała A.
    Skotnicki A.B.
    Journal of Medical Case Reports, 8 (1)
  • [44] COMBINING SEVERAL MOLECULAR ABNORMALITIES IN IDENTIFICATION OF HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA IMPROVES RISK-STRATIFICATION
    Fiskvik, I.
    Delabie, J.
    Beiske, K.
    Leppa, S.
    Eriksson, M.
    Smeland, E.
    Holte, H.
    HAEMATOLOGICA, 2014, 99 : 413 - 414
  • [45] Limited efficacy of pixantrone in refractory diffuse large B-cell lymphoma
    Novakovic, Aleksander
    Boltezar, Lucka
    Novakovic, Barbara Jezersek
    ONCOLOGY LETTERS, 2020, 19 (03) : 2028 - 2034
  • [46] Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA
    Zhang, Sicong
    Zhang, Tingting
    Liu, Hengqi
    Zhao, Jing
    Zhou, Haifei
    Su, Xiaoxing
    Liu, Xianming
    Li, Lanfang
    Qiu, Lihua
    Qian, Zhengzi
    Zhou, Shiyong
    Gong, Wenchen
    Meng, Bin
    Ren, Xiubao
    He, Jin
    Wang, Xianhuo
    Zhang, Huilai
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 617 - 628
  • [47] Delayed Methotrexate Elimination Following High-dose Methotrexate Prophylaxis in High-risk Diffuse Large B-cell Lymphoma
    Akimoto, Masahiro
    Miyazaki, Takuya
    Takahashi, Hiroyuki
    Takeda, Takaaki
    Hibino, Yuto
    Tokunaga, Mayumi
    Ohashi, Takuma
    Matsumura, Ayako
    Teshigawara, Haruka
    Suzuki, Taisei
    Teranaka, Hiroshi
    Nakajima, Yuki
    Matsumoto, Kenji
    Hashimoto, Chizuko
    Fujimaki, Katsumichi
    Fujita, Hiroyuki
    Sakai, Rika
    Fujisawa, Shin
    Nakajima, Hideaki
    INTERNAL MEDICINE, 2025,
  • [48] Treatment of high-risk diffuse large B-cell lymphoma with intensified induction therapy and high-dose sequential therapy
    Rigacci, L
    Nassi, L
    Guidi, S
    Carrai, V
    Nozzoli, C
    Alterini, R
    Lombardini, L
    Bernardi, F
    Saccardi, R
    Vannucchi, A
    Bosi, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S245 - S245
  • [49] Rituximab, lenalidomide, and ibrutinib alone and combined with dose adjusted chemotherapy for patients with high risk diffuse large B-cell lymphoma.
    Westin, Jason R.
    Oki, Yasuhiro
    Fayad, Luis
    Nastoupil, Loretta J.
    Turturro, Francesco
    Hagemeister, Frederick B.
    Sathyanarayanan, Vishwanath
    Young, Ken H.
    McDonnell, Timothy
    Chuang, Hubert
    Zhou, Shouhao
    Neelapu, Sattva Swarup
    Davis, Richard Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Treatment of high-risk diffuse large B-cell lymphoma with intensified induction therapy and high-dose sequential therapy
    Rigacci, L
    Nassi, L
    Guidi, S
    Alterini, R
    Nozzoli, C
    Bernardi, F
    Bartalucci, E
    Lombardini, L
    Carrai, V
    Vannucchi, A
    Saccardi, R
    Bosi, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S243 - S243
12345